This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Machinery sectors have performed better than the manufacturing sector overall, and despite current challenges the next global downturn for manufacturing is not expected until late 2025 or early 2026. The next manufacturing downturn is expected in 2026, but to a lesser extent than in 2020. in 2022, compared to 3.3% for Europe.
MONTREAL — Last Fall, Pharmascience, a pharmaceutical company, announced a major $120 million sterile injectable manufacturing facility expansion at its Candiac site. Pharmascience hopes that by 2026, the company will have invested over $120 million to expand its facilities and more than triple its capacity with new equipment.
Replacing the existing robotics facilities at the site, the new Campus is planned to open in late 2026. The investment in our new Campus is driven by customer demand and projected market growth,” said Björn Rosengren, ABB CEO. Following important investments in China and the U.S,
(Credit: GlobeNewswire) EDMONTON — Construction is set to begin on a pharmaceutical manufacturing facility in the Edmonton Research Park that will provide Canadians with a supply of drugs. Construction for the CMPC is set to be completed by 2026. Investment includes $80.5 million in federal funding through PrairiesCan, $17.6
BARRIE MediPharm Labs announced a commercial agreement with Laboratrio Teuto, a pharmaceutical manufacturer and marketer in Brazil. Brazil’s medical cannabis market includes regulatory requirements such as: ANVISA onsite GMP Inspections: Ensuring adherence to certain pharmaceutical standards.
“Our life sciences and pharmaceutical capabilities are in demand and helping improve health outcomes in the communities we serve,” commented Ian L. .” The new spaces are expected to be operational by late 2026. MONTREAL — AtkinsRéalis Group Inc.,
Table of Contents Everything Electrified and Connected All at Once: New Challenges Facing SupplyChains, Best Practices and Lessons Learned Cybersecurity Threats in the Manufacturing Industry The New Era of U.S. Miller | vmiller@foley.com Nicholas J. With these changes comes the need for new technologies.
In March 2021 it received $415 million from Canada and another $55 million from the Ontario government, to build a flu vaccine plant at its Toronto campus by 2026. Sanofi is among the 12 companies expanding production capacity now.
Click here to download Top Transformations Impacting Growth in Global Molecular Biomarkers Market, Forecast to 2030 Rank Strategic Imperative Category Strategic Imperative Impact Score (%) Timeline Duration Growth Curve 1 Industry Convergence Cross-sector partnerships between pharmaceuticals and AI companies to enhance biomarker precision 72 2025-2039 (..)
Theres a lot of optimism and a lot of signals right now that 2025, and even into 2026 and 2027, being strong years for automation, Alex Shikany, executive vice president of A3, told The Robot Report last week at Collaborate North America 2025. in units and 0.1% in revenue over 2023. .”
We organize all of the trending information in your field so you don't have to. Join 45,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content